8-K: Broadway Financial to Restate Past Financials

Broadway Financial Corporation announced that its previously issued financial statements for fiscal years 2023 and 2024, and several interim quarters, should no longer be relied upon due to an accounting error.

Summary

• The Audit Committee of Broadway Financial Corporation's Board of Directors concluded on October 15, 2025, that the company's audited consolidated financial statements for fiscal years ended December 31, 2024 and 2023, and unaudited interim consolidated financial statements for quarters ended March 31, 2024, June 30, 2024, September 30, 2024, and March 31, 2025, should no longer be relied upon.
• The non-reliance is due to an error related to certain loan participation agreements, requiring these financial statements to be restated.
• The restatement will record loan participation agreements in accordance with Accounting Standards Codification Topic 860.
• The restatement will impact the Consolidated Statements of Financial Condition, related interest income and interest expense in the Consolidated Statements of Operations, and the allowance for credit losses for the affected periods.
• The company will file amendments to its Annual Report on Form 10-K for fiscal year 2024 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
• Management identified a material weakness in the company's internal control over financial reporting as of the original filing dates of the affected financials, which will be reported in the amendments.

Sentiment

Score: 2

Explanation: The non-reliance on past financial statements, the need for restatement, and the identification of a material weakness in internal controls are significant negative events that undermine investor confidence and suggest operational deficiencies.

Negatives

• Previously issued audited and unaudited financial statements for multiple periods can no longer be relied upon.
• The company is required to restate its financial reports for fiscal years 2023 and 2024, and several interim quarters.
• Management identified a material weakness in internal control over financial reporting.
• The accounting error relates to core banking operations, specifically loan participation agreements, which could impact investor confidence and regulatory standing.

Risks

• Additional corrections to the company's consolidated financial statements may result from the restatement process.
• Actual outcomes may differ materially from forward-looking statements due to known and unknown risks, uncertainties, and other factors beyond the company's control.
• Investors are cautioned not to place undue reliance on forward-looking statements.

Future Outlook

The company will restate the affected financial statements and file amendments to its Annual Report on Form 10-K for fiscal year 2024 and Quarterly Report on Form 10-Q for Q1 2025. Forward-looking statements involve known and unknown risks, including potential additional corrections to the consolidated financial statements.

Industry Context

In the banking industry, accurate financial reporting is paramount for maintaining depositor and investor confidence, as well as regulatory compliance. A restatement due to accounting errors, particularly concerning loan agreements, can raise concerns about asset quality, risk management, and the overall financial health of the institution, potentially leading to increased scrutiny from regulators and rating agencies.

Corporate Governance

Stakeholder Impact

• Shareholders: Loss of confidence in financial reporting, potential negative impact on stock price, and uncertainty regarding the company's true financial performance.
• Investors: Inability to rely on historical financial data for investment decisions, leading to increased perceived risk and potential divestment.
• Regulatory Authorities (SEC): Increased scrutiny and potential enforcement actions due to non-compliance with reporting standards and the identified material weakness.
• Creditors: May reassess the company's financial health and creditworthiness, potentially impacting borrowing costs or access to capital.
• Management/Employees: Increased workload and resources dedicated to the restatement process, potential reputational damage to the company and its leadership.

Next Steps

• Restate the audited consolidated financial statements for fiscal years ended December 31, 2024 and 2023.
• Restate the unaudited interim consolidated financial statements for quarters ended March 31, 2024, June 30, 2024, September 30, 2024, and March 31, 2025.
• File amendments to the Annual Report on Form 10-K for fiscal year 2024 and the Quarterly Report on Form 10-Q for Q1 2025 with the SEC.
• Report the identified material weakness in internal control over financial reporting in the amendments.

Key Dates

Recommendation

The non-reliance on multiple periods of financial statements, including audited annual reports, coupled with the identification of a material weakness in internal controls, signals significant financial reporting issues. This creates substantial uncertainty regarding the company's true financial position and operational integrity. Investors should consider selling to mitigate exposure to potential further negative revisions, regulatory actions, and a likely decline in investor confidence and share price until these issues are fully resolved and new, reliable financials are issued.

Keywords

Broadway Financial Corporation, BYFC, Financial Restatement, SEC Filing, 8-K, Accounting Error, Loan Participation Agreements, Material Weakness, Internal Control, Financial Reporting, Banking, City First Bank